egtazic acid has been researched along with Tachycardia, Supraventricular in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brundel, BJ; Burstein, B; Chartier, D; Dobrev, D; Maguy, A; Nattel, S; Qi, XY; Villeneuve, LR; Xiao, L; Yeh, YH | 1 |
Belardinelli, L; Shryock, JC; Song, Y | 1 |
2 other study(ies) available for egtazic acid and Tachycardia, Supraventricular
Article | Year |
---|---|
Cellular signaling underlying atrial tachycardia remodeling of L-type calcium current.
Topics: Action Potentials; Animals; Calcineurin; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Signaling; Calmodulin; Cardiac Pacing, Artificial; Cells, Cultured; Chelating Agents; Dogs; Egtazic Acid; Heart Atria; Myocytes, Cardiac; NFATC Transcription Factors; Nimodipine; Potassium; RNA, Messenger; Sulfonamides; Tachycardia, Supraventricular; Tacrolimus; Time Factors; Transcription, Genetic | 2008 |
An increase of late sodium current induces delayed afterdepolarizations and sustained triggered activity in atrial myocytes.
Topics: Acetanilides; Action Potentials; Animals; Anti-Arrhythmia Agents; Calcium; Cardiotonic Agents; Chelating Agents; Cnidarian Venoms; Egtazic Acid; Guinea Pigs; Heart Atria; Heart Conduction System; Myocytes, Cardiac; Patch-Clamp Techniques; Piperazines; Ranolazine; Ryanodine; Ryanodine Receptor Calcium Release Channel; Sodium; Sodium Channel Blockers; Sodium Channels; Sodium-Calcium Exchanger; Tachycardia, Supraventricular; Tetrodotoxin; Thiourea; Time Factors; Up-Regulation | 2008 |